Academic literature on the topic 'Measles-Mumps-Rubella Vaccine $$x adverse effects'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Measles-Mumps-Rubella Vaccine $$x adverse effects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Measles-Mumps-Rubella Vaccine $$x adverse effects"

1

Ogawa, Taku, Fukumi Uchiyama-Nakamura, Aiko Sugata-Tsubaki, et al. "Antibody Response to Live Attenuated Vaccines in Adults in Japan." Open Medicine 11, no. 1 (2016): 482–88. http://dx.doi.org/10.1515/med-2016-0085.

Full text
Abstract:
AbstractThe purpose of this study was to examine the efficacy rendered with a single dose of live attenuated measles, rubella, mumps, and varicella containing vaccine.We inoculated healthcare workers (HCWs) with a single dose of vaccine to a disease lacking in antibody titer for those not meeting the criteria of our hospital (measles: <16.0 (IgG enzyme immunoassay (EIA)), rubella: ≤1:32 (hemagglutination-inhibition), mumps: <4.0 (IgG EIA), and varicella: <4.0 (IgG EIA)). At 28–60 days after vaccination, the antibody titer was tested again.We included 48 HCWs. A total of 32, 15, 31, an
APA, Harvard, Vancouver, ISO, and other styles
2

K., Geetha. "Therapeutic evaluation of intralesional measles, mumps and rubella vaccine in palmoplantar warts." International Journal of Research in Dermatology 5, no. 4 (2019): 827. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20194676.

Full text
Abstract:
<p class="abstract"><strong>Background:</strong> Warts are common viral infections of the skin caused by human papilloma virus. Most of the treatment modalities for common warts remain unsatisfactory. Immunotherapy has become one of the important therapeutic modality. This study was conducted to evaluate the efficacy of intralesional measles, mumps and rubella (MMR) vaccine immunotherapy in palmoplantar warts.</p><p class="abstract"><strong>Methods:</strong> 60 patients of various age groups and both sexes who have single or multiple palmoplantar warts
APA, Harvard, Vancouver, ISO, and other styles
3

Rager-Zisman, Bracha, Elina Bazarsky, Agneta Skibin, et al. "Differential Immune Responses to Primary Measles-Mumps-Rubella Vaccination in Israeli Children." Clinical Diagnostic Laboratory Immunology 11, no. 5 (2004): 913–18. http://dx.doi.org/10.1128/cdli.11.5.913-918.2004.

Full text
Abstract:
ABSTRACT Measles remains an important cause of morbidity and mortality worldwide, primarily due to problems associated with delivery of the live attenuated vaccine to susceptible populations. In some developed countries, there is concern about the effects of immunization on the immune system. In this study, we analyzed the responses of 12-month-old Bedouin and Jewish children living in Israel to routine measles-mumps-rubella (MMR) vaccination. Seroconversion to measles was 99% in Bedouin and 79% in Jewish children (P < 0.01), and that to mumps and rubella was 92 to 100% in both groups. Meas
APA, Harvard, Vancouver, ISO, and other styles
4

Bellavite, Paolo, and Alberto Donzelli. "Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data." F1000Research 9 (September 28, 2020): 1176. http://dx.doi.org/10.12688/f1000research.26523.1.

Full text
Abstract:
Vaccine surveillance programs are crucial for the analysis of the vaccine’s safety profile and the guidance of health policies. The Epidemiological Observatory of the Italian Apulia Region carried out an active surveillance program of adverse effects following immunization (AEFI) after the first dose of the measles-mumps-rubella-varicella (MMRV) vaccine, finding 462 AEFIs per 1000 doses, with 11% rated serious. Applying the World Health Organization (WHO) causality assessment algorithm, 38 serious AEFIs/1000 enrolled were classified as ‘consistent causal associations’ with MMRV immunization. S
APA, Harvard, Vancouver, ISO, and other styles
5

Bellavite, Paolo, and Alberto Donzelli. "Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data." F1000Research 9 (January 6, 2021): 1176. http://dx.doi.org/10.12688/f1000research.26523.2.

Full text
Abstract:
Vaccine surveillance programs are crucial for the analysis of the vaccine’s safety profile and the guidance of health policies. The Epidemiological Observatory of the Italian Apulia Region carried out an active surveillance program of adverse effects following immunization (AEFI) after the first dose of the measles-mumps-rubella-varicella (MMRV) vaccine, finding 462 AEFIs per 1000 doses, with 11% rated serious. Applying the World Health Organization (WHO) causality assessment algorithm, 38 serious AEFIs/1000 enrolled were classified as ‘consistent causal associations’ with MMRV immunization. S
APA, Harvard, Vancouver, ISO, and other styles
6

Omersel, Jasna, and Nataša Karas Kuželički. "Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines." Journal of Clinical Medicine 9, no. 11 (2020): 3561. http://dx.doi.org/10.3390/jcm9113561.

Full text
Abstract:
Precision medicine approaches based on pharmacogenomics are now being successfully implemented to enable physicians to predict more efficient treatments and prevention strategies for a given disease based on the genetic background of the patient. This approach has already been proposed for vaccines, but research is lagging behind the needs of society, and precision medicine is far from being implemented here. While vaccinomics concerns the effectiveness of vaccines, adversomics concerns their side effects. This area has great potential to address public concerns about vaccine safety and to pro
APA, Harvard, Vancouver, ISO, and other styles
7

Scheifele, David W., Gordean L. Bjornson, William G. Meekison, Roland Guasparini, and Leslie A. Mitchell. "Evaluation ofHaemophilus influenzaeType B Conjugate Vaccine (Meningococcal Protein Conjugate) in Canadian Infants." Canadian Journal of Infectious Diseases 5, no. 2 (1994): 75–81. http://dx.doi.org/10.1155/1994/479313.

Full text
Abstract:
Objective: To assess adverse effects and immune responses with a three-dose series ofHaemophilus influenzaetype b meningococcal protein conjugate (PedvaxHIB or Hib.OMP) vaccine, including any immunological response alterations from concurrent administration with routine vaccines for infants.Design: Randomized, controlled trial with treatment group crossover for dose 3.Setting: Two public health units near Vancouver.Participants: One hundred and ten healthy infants eight to 14 weeks old were enrolled; 105 completed the study (95%).Interventions: All participants received two doses of diphtheria
APA, Harvard, Vancouver, ISO, and other styles
8

D'Souza, Jennifer, and Timothy Todd. "Measles-Mumps-Rubella Vaccine and the Development of Autism or Inflammatory Bowel Disease: The Controversy Should End." Journal of Pediatric Pharmacology and Therapeutics 8, no. 3 (2003): 187–99. http://dx.doi.org/10.5863/1551-6776-8.3.187.

Full text
Abstract:
Vaccines have been administered to millions of individuals, usually infants and children, with few serious adverse effects. In 1998 a report suggested that there may be a link between the measles-mumps-rubella vaccine and the development of behavioral abnormalities (i.e., autism) and inflammatory bowel disease in children. This report generated considerable media and political attention, which many feared would result in a decreased willingness of parents to immunize their children against these contagious diseases. Over the past decade, an increasing number of healthcare practitioners have be
APA, Harvard, Vancouver, ISO, and other styles
9

O'Brien, Timothy J. "Pediatric Immunizations: A Review." Journal of Pharmacy Practice 2, no. 1 (1989): 21–27. http://dx.doi.org/10.1177/089719008900200104.

Full text
Abstract:
Since Edward Jenner discovered that injecting cowpox virus into humans could prevent smallpox, the science of immunology has produced many vaccines that have virtually eradicated some of the worst childhood diseases known to mankind. Along with this great benefit, some vaccines carry with them potentially serious side effects. This review considers the mechanisms of immunology and how these are taken advantage of in vaccine production. The pharmacist is then acquainted with each of the vaccines used in childhood: measles, mumps, rubella (MMR); diphtheria, tetanus toxoids, and pertussis (DTP);
APA, Harvard, Vancouver, ISO, and other styles
10

Nofal, Ahmad, Reda Ezz El-arab, Mohamed Nasr, and Rania Alakad. "Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional Candida Antigen in the Treatment of Common and Plantar Warts." Journal of Cutaneous Medicine and Surgery 25, no. 4 (2021): 377–83. http://dx.doi.org/10.1177/1203475421991130.

Full text
Abstract:
Background Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited. Objective To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine compared with intralesional Candida antigen for the treatment of multiple common and plantar warts. Methods Sixty-eight adult patients with multiple common and plantar warts were randomly assigned into two groups, each containing 34 patients. The first group received intralesional MMR vaccine, while the second group received intrale
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Measles-Mumps-Rubella Vaccine $$x adverse effects"

1

Carlton, Rashad. "The Association between the Measles, Mumps, and Rubella Vaccine and the Development of Autism: A Meta-Analysis." [Tampa, Fla] : University of South Florida, 2008. http://purl.fcla.edu/usf/dc/et/SFE0002301.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Measles-Mumps-Rubella Vaccine $$x adverse effects"

1

Callous disregard: Autism and vaccines -- the truth behind a tragedy. Skyhorse Pub., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Waging war on the autistic child: The Arizona 5 and the legacy of Baron von Munchausen. Skyhorse Pub., 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Stratton Kathleen, Institute of Medicine (U.S.). Board on Health Promotion and Disease Prevention., and Institute of Medicine (U.S.). Immunization Safety Review Committee., eds. Immunization safety review: Measles-mumps-rubella vaccine and autism. National Academy Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Kathleen Stratton, Alicia Gable, and Padma Shetty. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. National Academies Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wakefield, Andrew J., and Jenny McCarthy. Callous Disregard: Austim and Vaccines - The Truth Behind a Tragedy. Skyhorse Publishing Company, Incorporated, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wakefield, Andrew J. Callous Disregard: Autism and Vaccines--The Truth Behind a Tragedy. Skyhorse, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Defeating Autism: A Damaging Delusion. Routledge, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wakefield, Andrew J. Waging War on the Autistic Child: The Arizona 5 and the Legacy of Baron Von Munchausen. Skyhorse Publishing Company, Incorporated, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!